Aclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference

ACRS 11.26.2024

Full Press ReleaseSEC FilingsOur ACRS Tweets

About Gravity Analytica

Recent News

  • 01.06.2025 - Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  • 12.03.2024 - Piper Sandler 36th Annual Healthcare Conference

Recent Filings

  • 01.13.2025 - 8-K Current report
  • 01.13.2025 - EX-99.1 EX-99.1
  • 01.03.2025 - 4 Statement of changes in beneficial ownership of securities
PDF Version
Aclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference
November 26, 2024

WAYNE, Pa.,Nov. 26, 2024(GLOBE NEWSWIRE) --Aclaris Therapeutics, Inc.(NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that members of the Aclaris management team will participate in a fireside chat during the Piper Sandler 36thAnnual Healthcare Conference onTuesday, December 3, 2024at1:00 PM ETinNew York, New York.

A webcast of the fireside chat may be accessed through the “Events” page of the “Investors” section of Aclaris’ website,www.aclaristx.com. The webcast will be archived for at least 30 days on the Aclaris website.

AboutAclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc.is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visitwww.aclaristx.com.

Aclaris Therapeutics Contact:

investors@aclaristx.com

Primary Logo

Source: Aclaris Therapeutics, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com